Kircik, Leon H.
Stein Gold, Linda
Gold, Michael
Weiss, Jonathan S.
Harper, Julie C.
Del Rosso, James Q.
Bunick, Christopher G.
Bhatia, Neal
Tanghetti, Emil A.
Eichenfield, Lawrence F.
Baldwin, Hilary
Draelos, Zoe D.
Callender, Valerie D.
Han, George
Gooderham, Melinda J.
Sadick, Neil
Lupo, Mary P.
Lain, Edward
Werschler, William Philip
Clinical trials referenced in this document:
Documents that mention this clinical trial
Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis
https://doi.org/10.1007/s13555-024-01155-7
Documents that mention this clinical trial
Triple Combination Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% for Acne: Efficacy and Safety from a Pooled Phase 3 Analysis
https://doi.org/10.1007/s13555-024-01155-7
Article History
Received: 7 February 2024
Accepted: 2 April 2024
First Online: 9 May 2024
Declarations
:
: Leon H. Kircik has served as either a consultant, speaker, advisor or an investigator for Allergan, Almirall, Epi Health, Galderma, Novartis, Ortho Dermatologics, and Sun Pharma. Linda Stein Gold has served as investigator/consultant or speaker for Ortho Dermatologics, LEO Pharma, Dermavant, Incyte, Novartis, AbbVie, Pfizer, Sun Pharma, UCB, Arcutis, and Lilly. Michael Gold has acted as an investigator, advisor, speaker, and consultant for Ortho Dermatologics. Jonathan S. Weiss is a consultant, speaker, advisor, and/or researcher for AbbVie, Ortho Dermatologics, Janssen Biotech, Dermira, Almirall, Brickell Biotech, DermTech, and Scynexis. Julie C. Harper has received honoraria from Aclaris, Almirall, BioPharmX, Cassiopea, Cutanea, Dermira, Foamix, Galderma, LaRoche-Posay, Ortho Dermatologics, and Sun Pharma. James Q. Del Rosso has served as a consultant, investigator, and/or speaker for Ortho Dermatologics, AbbVie, Amgen, Arcutis, Cutera, Dermavant, EPI Heath, Galderma, Incyte, JEM Health, La Roche-Posay, LEO Pharma, Lilly, L’Oreal, MC2 Therapeutics, Pfizer, Strata, Sun Pharma, and UCB. Christopher G. Bunick has served as an investigator for AbbVie, Almirall, Timber, and Palvella; a consultant for AbbVie, Almirall, Apogee, Arcutis, Eli Lilly, EPI Health/Novan, LEO Pharma, Novartis, Ortho Dermatologics, Pfizer, Sanofi-Regeneron, and UCB; and a speaker for and received honoraria from Allergan, Almirall, LEO Pharma, and UCB. Neal Bhatia has served as advisor, consultant, and investigator for AbbVie, Almirall, Biofrontera, BI, Brickell, BMS, EPI Health, Ferndale, Galderma, InCyte, ISDIN, J&J, LaRoche-Posay, LEO Pharma, Ortho Dermatologics, Regeneron, Sanofi, Sun Pharma, Verrica, and Vyne. Emil A. Tanghetti has served as speaker for Novartis, Ortho Dermatologics, Sun Pharma, Lilly, Galderma, AbbVie, and Dermira; served as a consultant/clinical studies for Hologic, Ortho Dermatologics, and Galderma; and is a stockholder for Accure. Lawrence F. Eichenfield has received honoraria for consulting services from AbbVie, BMS, Dermata, Dermira, Dermavant, Eli Lilly, Forte Pharma, Galderma, Incyte, J&J, Otsuka, Novartis, Pfizer, Regeneron Pharmaceuticals, Inc., Sanofi Genzyme, and Ortho Dermatologics; and study support (to institution) from AbbVie, Bausch Health, Dermira, Eli Lilly and Company, Galderma, Incyte, Pfizer, Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. Hilary Baldwin has served as advisor, investigator, and on speakers’ bureaus for Almirall, Cassiopea, Foamix, Galderma, Ortho Dermatologics, Sol Gel, and Sun Pharma. Zoe D. Draelos received funding from Ortho Dermatologics. Valerie D. Callender has served as an investigator, consultant, or speaker for Acne Store, Almirall, Aerolase, AbbVie, Allergan Aesthetics, Avava, Avita Medical, Beiersdorf, Cutera, Dermavant, Eli Lilly, Epi Health, Galderma, Janssen, Jeune Aesthetics, L’Oréal, Ortho Dermatologics, Pfizer, Prollineum, Regeneron, Scientis, Sente, SkinBetter science, SkinCeuticals, Symatese, UCB, and UpToDate. George Han is or has been an investigator, consultant/advisor, or speaker for AbbVie, Athenex, Boehringer Ingelheim, Bond Avillion, Bristol-Myers Squibb, Celgene, Eli Lilly, Novartis, Janssen, LEO Pharma, MC2, Ortho Dermatologics, PellePharm, Pfizer, Regeneron, Sanofi Genzyme, Sun Pharma, and UCB. Melinda J. Gooderham has served as investigator/consultant or speaker for AbbVie, Akros Pharma, Amgen, Arcutis Biotherapeutics, Aslan, Aristea, AnaptysBio, Bausch, BMS, Boehringer Ingelheim, Coherus BioSciences, Dermira, Dermavant, Eli Lilly, Galderma, GSK, Incyte, Inmagene, Janssen, Kyowa Kirin, LEO Pharma, MedImmune, Meiji, Merck, Moonlake, Nimbus, Novartis, Pfizer, Regeneron Pharmaceuticals, Inc., Reistone, Roche, Sanofi, Sun Pharma, Takeda, Tarsus, Union, UCB and Ventyx. Neil Sadick has served on advisory boards, as a consultant, investigator, speaker, and/or other and has received honoraria and/or grants/research funding from Almirall, Actavis, Allergan, Anacor Pharmaceuticals, Auxilium Pharmaceuticals, Bausch Health, Bayer, Biorasi, BTG, Carma Laboratories, Cassiopea, Celgene Corporation, Cutera, Cynosure, DUSA Pharmaceuticals, Eclipse Medical, Eli Lilly and Company, Endo International, EndyMed Medical, Ferndale Laboratories, Galderma, Gerson Lehrman Group, Hydropeptide, Merz Aesthetics, Neostrata, Novartis, Nutraceutical Wellness, Palomar Medical Technologies, Prescriber's Choice, Regeneron, Roche Laboratories, Samumed, Solta Medical, Storz Medical AG, Suneva Medical, Vanda Pharmaceuticals, and Venus Concept. Mary P. Lupo has served as a speaker, investigator, and/or on advisory boards for Ortho Dermatologics, Bausch Health US, Evolus, Revance, Eirion, Prolennium, Chemocentryx, Therapeutics Incorporated, Brickell, Endo, Cutera, In Mode, Revision, and Merz. Edward (Ted) Lain has served as investigator, consultant and/or speaker for Ortho Dermatologics, AbbVie, Almirall, Amgen, Arcutis, Dermavant, EPI Health, Galderma, Incyte, LEO Pharma, Novartis, Eli Lilly, Pfizer, Sun Pharma, UCB, Endo International, ChemoCentryx, Biorasi, Sirnaomics, Evelo Biosciences, Concert Pharmaceuticals, Cara Therapeutics, Castle Biosciences, Mindera, Biofrontera, Alfasigma, AiViva Biopharma, Anaptys Bio, Bausch Health, Dr Reddy’s, Trevi Therapeutics. William Philip Werschler has served as an investigator for Ortho Dermatologics.
: These studies were carried out in accordance with principles of Good Clinical Practice (GCP) and the Declaration of Helsinki. Study protocols across all study centers were approved by the same central institutional review board (Advarra IRB, Columbus, MD, USA). All participants or their legal guardians provided written informed consent before entering the clinical trial from which the data were derived. Additional informed consent was obtained from all individual participants for whom identifying information/photographs are included in this article.